SHEDDING, SECRETION, & TRANSFER OF GLYCOSPHINGOLIPIDS
SHEDDING, SECRETION, & TRANSFER OF GLYCOSPHINGOLIPIDS
批准号:
3458502
负责人:
STEVEN L SPITALNIK
金额:
$9.38万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1992-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glycosphingolipids are important constituents of cell membranes.
The tremendous diversity of oligosaccharide structure and the
number of glycosyltransferases necessary for synthesizing these
structures suggest that they may have significant functions. As
examples, they do function as human blood group allo- and
autoantigens, as receptors for viruses and toxins, as tumor
markers, and are involved in cell-cell interactions. Some of these
functions, such as toxin binding and antigenicity, have been
passively transferred to cells incubating the cells with the
appropriate glycosphingolipid. Many tumor-associated
glycosphingolipids have been described and some of these are shed
by the tumor cells. Since some glycosphingolipids suppress
immune responsiveness in vitro, glycosphingolipids shed from
tumors may contribute to the immunosuppression found with some
forms of human cancer.
Glycosphingolipids form micelles in water since the monomers are
virtually insoluble. Significant concentrations of
glycosphingolipids are found in plasma and they are exclusively
associated with lipoproteins. Little is known about the
mechanisms by which glycosphingolipids enter plasma, whether by
secretion, shedding from membranes, or absorption from cell
membranes by lipoproteins.
The ultimate goal of this proposal is to understand the
mechanisms by which glycosphingolipids are secreted or shed from
normal and malignant cells, interact with plasma lipoproteins,
transfer between lipoproteins, and transfer from lipoproteins onto
or into other cells. Human tumor cell lines will be used as models
to study the secretion or shedding of glycosphingolipids and the
role of lipoproteins in this process. Blood from various individuals
with differing glycosphingolipid blood group antigens will be used
to study the kinetics and mechanisms of transfer of
glycosphingolipids between plasma lipoproteins and between
lipoproteins and human erythrocytes, lymphocytes, and platelets.
This work will lead to a better understanding of the way
exogenous glycosphingolipids affect cell function and cell surface
topography. It will also provide deeper insight into how
lipoproteins interact with each other and with cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harmful effects of red blood cell transfusions are mediated by iron
-
批准号:8681508
-
项目类别:
-
资助金额:$57.61万
-
财政年份:2013
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Harmful effects of red blood cell transfusions are mediated by iron
-
批准号:8450960
-
项目类别:
-
资助金额:$54.78万
-
财政年份:2013
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Mechanisms of effect of iron status & interventions on malaria & other infections
-
批准号:7941975
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Harmful effects of transfusion of older stored red cells: iron and inflammation
-
批准号:8298229
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Harmful effects of transfusion of older stored red cells: iron and inflammation
-
批准号:7760674
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Mechanisms of effect of iron status & interventions on malaria & other infections
-
批准号:8130649
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Mechanisms of effect of iron status & interventions on malaria & other infections
-
批准号:8312476
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Harmful effects of transfusion of older stored red cells: iron and inflammation
-
批准号:8134167
-
项目类别:
-
资助金额:$8.28万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Harmful effects of transfusion of older stored red cells: iron and inflammation
-
批准号:8111203
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Harmful effects of transfusion of older stored red cells: iron and inflammation
-
批准号:7934521
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Mechanisms of effect of iron status & interventions on malaria & other infections
-
批准号:7879692
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Epitope masking reagents in transfusion medicine
-
批准号:7238343
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2007
-
负责人:STEVEN L SPITALNIK
-
依托单位:
Epitope masking reagents in transfusion medicine
-
批准号:7421043
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2007
-
负责人:STEVEN L SPITALNIK
-
依托单位:
GLYCOSYLATION OF AMYLOID PRECURSOR PROTEINS
-
批准号:6234459
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1997
-
负责人:STEVEN L SPITALNIK
-
依托单位:
BIOLOGY OF THE GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:2222726
-
项目类别:
-
资助金额:$17.85万
-
财政年份:1991
-
负责人:STEVEN L SPITALNIK
-
依托单位:
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:3365277
-
项目类别:
-
资助金额:$16.33万
-
财政年份:1991
-
负责人:STEVEN L SPITALNIK
-
依托单位:
BIOLOGY OF THE GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:2222727
-
项目类别:
-
资助金额:$18.5万
-
财政年份:1991
-
负责人:STEVEN L SPITALNIK
-
依托单位:
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:3365279
-
项目类别:
-
资助金额:$17.4万
-
财政年份:1991
-
负责人:STEVEN L SPITALNIK
-
依托单位:
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:3365278
-
项目类别:
-
资助金额:$16.75万
-
财政年份:1991
-
负责人:STEVEN L SPITALNIK
-
依托单位:
BIOLOGY OF THE GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:2222725
-
项目类别:
-
资助金额:$18.37万
-
财政年份:1991
-
负责人:STEVEN L SPITALNIK
-
依托单位: